Group | Case number | Dry mouth | Muscular soreness | Gastrointestinal reactions | Incidence rates of adverse reactions | |||
Case number | % | Case number | % | Case number | % | % | ||
Observation group | 48 | 1 | 2.13 | 1 | 2.13 | 1 | 2.13 | 3 (2.22) |
Control group | 48 | 3 | 2.22 | 3 | 2.22 | 4 | 2.27 | 10 (2.63) |